Approval · Notice of Compliance 10235 · 2009
APTIVUS: Notice of Compliance 10235
Issued June 3, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10235
- Date
- June 3, 2009
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph - addition of 48/96 week data
- Therapeutic class
- Non-peptidic protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APTIVUS | Not yet assigned | — |
Medicinal ingredients
- TIPRANAVIR 250 MG per CAP